LATEST TWEETS - CURATED BY HASH FINANCE

Kiniksa Pharmaceuticals $KNSA Sets New 52-Week Low at $8.94 https://t.co/EYm5W3Bk2X
-$0.74 EPS Expected for Kiniksa Pharmaceuticals Ltd $KNSA This Quarter https://t.co/E5gxkJkSgX
-$0.74 Earnings Per Share Expected for Kiniksa Pharmaceuticals Ltd $KNSA This Quarter https://t.co/13YbAsn6QF
Kiniksa Pharmaceuticals $KNSA Upgraded to Buy by Zacks Investment Research https://t.co/nB095QUout
Kiniksa Pharmaceuticals $KNSA Upgraded to Buy by Zacks Investment Research https://t.co/cQjZKF9oPq
Kiniksa Pharmaceuticals $KNSA Lifted to Buy at Zacks Investment Research https://t.co/N1jLvsI8An
Kiniksa Pharmaceuticals $KNSA Lifted to Buy at Zacks Investment Research https://t.co/xJISvTrr3N
Wondering about risks of $KNSA? The 63-day volatility is 34.13% https://t.co/j50KJpoWF8
-$0.74 EPS Expected for Kiniksa Pharmaceuticals Ltd $KNSA This Quarter https://t.co/HSTMPGGmWq #markets
-$0.74 EPS Expected for Kiniksa Pharmaceuticals Ltd $KNSA This Quarter https://t.co/NUeEqzI4Yv #stocks
-$0.74 Earnings Per Share Expected for Kiniksa Pharmaceuticals Ltd $KNSA This Quarter https://t.co/lmW6fQL0hl
Kiniksa Pharmaceuticals $KNSA Stock Rating Reaffirmed by Wedbush https://t.co/lp5H3nUCBo
Kiniksa Pharmaceuticals $KNSA Stock Rating Reaffirmed by Wedbush https://t.co/UlTF7naG6J
Kiniksa Pharmaceuticals $KNSA PT Lowered to $35.00 at JMP Securities https://t.co/LBPUCREEWH
Kiniksa Pharmaceuticals $KNSA Upgraded by Zacks Investment Research to Buy https://t.co/oOBadSyO8k
Kiniksa Pharmaceuticals $KNSA Raised to Buy at Zacks Investment Research https://t.co/7n1nPK5vxh
Kiniksa Pharmaceuticals $KNSA Upgraded by Zacks Investment Research to Buy https://t.co/N1GH6eIjuu
Kiniksa Pharmaceuticals $KNSA Earns “Buy” Rating from Wedbush https://t.co/7nT8rdhPQP
Kiniksa Pharmaceuticals Ltd $KNSA Forecasted to Post Q3 2019 Earnings of -$0.75 Per Share https://t.co/ewCtPzYd0B
Kiniksa Pharmaceuticals Ltd $KNSA Forecasted to Post Q3 2019 Earnings of -$0.75 Per Share https://t.co/cx20y9SO6J
Wedbush Comments on Kiniksa Pharmaceuticals Ltd’s Q1 2020 Earnings $KNSA https://t.co/7c2pVmTnI3
Kiniksa Pharmaceuticals $KNSA Announces Quarterly Earnings Results, Beats Expectations By $0.03 EPS https://t.co/USrEBegwfT
Kiniksa Pharmaceuticals $KNSA Issues Earnings Results, Beats Expectations By $0.03 EPS https://t.co/rOYmwxCd6l
Kiniksa Pharmaceuticals $KNSA Issues Earnings Results, Beats Expectations By $0.03 EPS https://t.co/FgwsFiYnkz
Kiniksa Pharmaceuticals $KNSA Price Target Lowered to $35.00 at JMP Securities https://t.co/urQdskTsZ1
Kiniksa Pharmaceuticals $KNSA Given “Buy” Rating at Wedbush https://t.co/Jfsh4TcA2b